BactiVac Phase 2
Lead Research Organisation:
University of Birmingham
Department Name: Institute of Immunology & Immunotherapy
Abstract
"BactiVac was established in 2017 with a mission to advance vaccine development against bacterial infections of global significance to reduce disease, death, and antimicrobial resistance, and enhance economic development. We have brought together academia, industry, policymakers and funders from high-income countries and low- and middle-income countries (LMICs) in a network of over 1,600 members from 83 countries, with 49% of membership from LMICs. We have supported member collaborations in vaccine development through Catalyst Project Awards which have leveraged 545% of follow-on funding. We have delivered key trainings and supported Catalyst Training Awards that facilitate specific training
exchanges. Annual Network Meetings have brought the Network membership together and we have advocated for bacterial vaccines at all available opportunities. The goal of BactiVac Phase 2 is to enhance Network impact. This will be achieved through building on the successes of Phase 1 with further Catalyst Project Awards, Annual Network Meetings and Catalyst Training Awards. As an established network, we will expand advocacy initiatives and improve communications through development and delivery of rich and engaging media content. Network growth will focus on
increasing industry interactions and strengthening links to organisations with aligned missions. This will enable BactiVac to become a network within a highly functioning network of networks, promoting bacterial vaccines."
exchanges. Annual Network Meetings have brought the Network membership together and we have advocated for bacterial vaccines at all available opportunities. The goal of BactiVac Phase 2 is to enhance Network impact. This will be achieved through building on the successes of Phase 1 with further Catalyst Project Awards, Annual Network Meetings and Catalyst Training Awards. As an established network, we will expand advocacy initiatives and improve communications through development and delivery of rich and engaging media content. Network growth will focus on
increasing industry interactions and strengthening links to organisations with aligned missions. This will enable BactiVac to become a network within a highly functioning network of networks, promoting bacterial vaccines."
Technical Summary
See attached document
Publications
Biswas P
(2024)
Targeted Bioimaging of Microencapsulated Recombinant LAB Vector Expressing Fluorescent Reporter Protein: A Non-invasive Approach for Microbial Tracking.
in ACS biomaterials science & engineering
Børud B
(2024)
Sweet complexity: O-linked protein glycosylation in pathogenic Neisseria.
in Frontiers in cellular and infection microbiology
Chisenga CC
(2024)
Diagnostic Accuracy of Saliva-based Testing as a Vibrio Cholerae Surveillance Tool among naturally-infected patients.
in Clinical and experimental immunology
Elumalai P
(2023)
Immunomodulators in Aquaculture and Fish Health
Lakshmi S
(2025)
Analysis of the efficacy of two molecular adjuvants, flagellin and IFN-?, on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus)
in Fish Physiology and Biochemistry
Ng'ombe H
(2024)
Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia.
in Vaccine
Rio-Tinto A
(2024)
Increase in methicillin-resistant Staphylococcus spp. colonization among pregnant individuals during COVID-19 pandemic.
in Scientific reports
| Description | Established in 2017, the BactiVac Network has formed new collaborations between academia and industry and provided seed-funding for bacterial vaccine projects leading to the development of new vaccine products. The most significant achievements of the Network to date include: 1. The Network now has 2,118 members across 92 countries, 52% of which are from LMICs, 14% are in industry with 43% of our members being female and 57% male. 2. In 2018, we held our first Inaugural Meeting of our Network at the University of Birmingham, UK with representation from 14 different countries. 3. In 2019, we welcomed yet more of our members to the 2nd Annual Network Meeting in order for our members to broaden connections but also provide an excellent forum for exchanging ideas and furthering research possibilities. 4. In 2021, more than 200 scientists, industry figures and policy makers from 30 countries around the world gathered online to share expertise at the BactiVac Virtual Network Conference. 5. In 2023, we hosted our 3rd Annual Network meeting in Kilifi, Kenya. This was hosted in collaboration with the KEMRI Wellcome Trust Research Programme where we welcomed 94 attendees with representation from 23 countries. 6. In February 2023, we also hosted The BactiVac Network & Microbiology Society Focused Meeting on Vaccines as Tools to Combat Antimicrobial Resistance at the Edgbaston Park Hotel here in Birmingham. 7. In October 2023, BactiVac was honoured to welcome 158 of our members to its 4th Annual Network meeting in Birmingham, UK with representation from 28 countries in order to offer unique, focussed opportunities to hear from experts in academia, industry, policy and funding bodies to highlight the tremendous work being undertaken. 8. In April 2024, BactiVac co-hosted a Royal Society Science+ Meeting meeting at the Royal Society, London, UK on 'Vaccines and Antimicrobial Resistance - from Science to Policy', attended by 250 in-person & 450 online, with a poster session and 20 Travel Bursaries awarded 9. In November 2024, BactiVac held it's 5th Annual Network Meeting in Ho Chi Minh City, Vietnam, in collaboration with The Oxford University Clinical Research Unit (OUCRU), attended by 176 Network members from 32 different countries and 20 Travel Bursaries were awarded 10. BactiVac has leveraged an additional £7.11M of additional funding, bringing the total Network funding to date to £9.31M, to support Network activities which represents 423% increase of funding from the original £2.2M award 11. BactiVac has funded a total of 90 catalyst projects across 9 rounds of funding. The total of £4.58M awarded to catalyst projects has leverage an additional £4.41M of institutional support. These projects have also gone on to leverage a total of £23.61M of follow-on funding which represents a 535% increase on the original amount awarded by the Network 12. BactiVac funded projects have produced a total of 42 publications from 28 of the awarded projects 13. The Network has awarded a total of 18 catalyst training awards and provided online training for key skills to 83 members across 24 countries with 76% of attendees based in LMICs |
| Exploitation Route | BactiVac brings together the global bacterial vaccinology community through hosting Annual Network Meetings, providing catalyst project funding and training opportunities to upskill our members and support capacity building, particularly in LMICs. The support and opportunities provided to our membership directly support the development of bacterial vaccines which is the core remit of the Network. BactiVac is also seem as an exemplar of how a Network should be run and how to meaningfully engage with LMICs. We have been approached by a number of organisations to discuss our approach to help inform and influence their strategies for delivery of activities and LMIC engagement, including CARBX, UKVN and the FAILSAFE Network hosted at the University of Exeter. |
| Sectors | Agriculture Food and Drink Education Healthcare Manufacturing including Industrial Biotechology Pharmaceuticals and Medical Biotechnology |
| URL | https://www.birmingham.ac.uk/bactivac |
| Description | Establishment of new collaborations between academia and industry and seed-funding for bacterial vaccine projects leading to the development of new vaccine products. Advocacy for bacterial vaccines nationally and internationally, e.g. with UK government, to help shape policy, particularly with reference to bacterial vaccines to combat antimicrobial resistance. |
| First Year Of Impact | 2018 |
| Sector | Agriculture, Food and Drink,Education,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
| Impact Types | Societal Economic Policy & public services |
| Description | Travel Bursary April 2024 - The BactiVac Network & Royal Society Science+ Meeting 29 - 30 April 2024 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Evaluation documentation received from the recipients of the bursary to attend the meeting demonstrated the knowledge gained and value of the attendance with testimonials presented in the URL listed below. |
| URL | https://www.birmingham.ac.uk/research/immunology-immunotherapy/research/bactivac/travel-bursaries/tr... |
| Description | Travel Bursary November 2024 - BactiVac 5th Annual Network Meeting 04 - 07 November 2024 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Evaluation documentation received from the recipients of the bursary to attend the meeting demonstrated the knowledge gained and value of the attendance with testimonials as follows: - Attending this conference was directly aligned with my work, providing a platform to network with researchers and experts across the spectrum of efforts to combat bacterial pathogens. - This annual meeting is a fabulous conference making a gathering of world renowned and budding researchers that leads to fruitful discussions and collaborative research for the befit of human welfare. - I had the opportunity to expand my scientific network, engage in detailed scientific discussion, and to stimulate new collaborations to progress my work. |
| URL | https://www.birmingham.ac.uk/research/immunology-immunotherapy/research/bactivac/travel-bursaries/tr... |
| Description | Bacterial Vaccines Network (BactiVac) |
| Amount | £1,400,000 (GBP) |
| Funding ID | PO Number: 569175 |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2023 |
| End | 03/2025 |
| Description | BactiVac - enhancing networking & collaboration with LMICs to support the development of bacterial vaccines |
| Amount | £81,233 (GBP) |
| Funding ID | 2210409 |
| Organisation | University of Birmingham |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 09/2022 |
| End | 03/2023 |
| Description | BactiVac Annual Network Meetings (2018 & 2019) |
| Amount | £27,337 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2019 |
| End | 06/2019 |
| Description | BactiVac Network online training provision for members based in LMICs |
| Amount | £29,270 (GBP) |
| Funding ID | 10056095 |
| Organisation | University of Birmingham |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 11/2024 |
| End | 03/2025 |
| Description | BactiVac Phase 2 |
| Amount | £999,998 (GBP) |
| Funding ID | 226684/Z/22/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2023 |
| End | 03/2027 |
| Description | BactiVac Phase 2 |
| Amount | £999,998 (GBP) |
| Funding ID | 226684/Z/22/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2023 |
| End | 11/2027 |
| Description | BactiVac Phase 2 - UK Vaccine Network |
| Amount | £700,000 (GBP) |
| Funding ID | 1005362 |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2024 |
| End | 03/2025 |
| Description | BactiVac Royal Society Science+ Meeting: 'Vaccines and Antimicrobial Resistance - from Science to Policy' |
| Amount | £35,375 (GBP) |
| Funding ID | 1005052 |
| Organisation | University of Birmingham |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 09/2023 |
| End | 03/2024 |
| Description | Communicating the importance of LMIC-relevant research |
| Amount | £15,789 (GBP) |
| Funding ID | Institute for Global Innovation (IGI) - Project reference 3111 |
| Organisation | University of Birmingham |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 07/2020 |
| Description | Desenvolvimento de métodos alternativos de rastreamento de Streptococcus do grupo B e avaliação de correlatos de proteção vacinal como estratégias de controle e prevenção de doenças neonatais associadas |
| Amount | R$ 68,000,000 (BRL) |
| Funding ID | EDITAL FAPERJ Nº 07/2023 - PROGRAMA DE APOIO À JOVEM CIENTISTA MULHER COM VÍNCULO EM ICTS DO ESTADO DO RIO DE JANEIRO |
| Organisation | Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro |
| Sector | Private |
| Country | Brazil |
| Start | 01/2024 |
| End | 12/2027 |
| Description | Development of GBS STVII 6-plex MIA scheme of work |
| Amount | £488,382 (GBP) |
| Organisation | PATH |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2024 |
| End | 05/2024 |
| Description | Enhancing critical mass in vaccinology in LMICs: Support for the Bacterial Vaccines (BactiVac) 3rd Annual Network Meeting 2020, Kilifi, Kenya |
| Amount | £20,000 (GBP) |
| Organisation | University of Birmingham |
| Department | Institute for Global Innovation |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 11/2019 |
| End | 06/2020 |
| Description | Multiplex Immuno Assay (MIA) Clinical Sample Testing of Inventprise Hexavalent Group B Streptococcus Conjugate Vaccine (CVIA 103) |
| Amount | £653,145 (GBP) |
| Organisation | PATH |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2024 |
| End | 07/2026 |
| Description | BactiVac Network and Royal Society Science+ Meeting 'Vaccines and Antimicrobial Resistance - from Science to Policy' |
| Organisation | The Royal Society |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Professor Cal MacLennan (BactiVac Co-Director) co-chaired this meeting with Dame Sally Davies. The meeting was organised following the selection of a proposal submitted by BactiVac to their Science+ meeting series. The meeting chairs identified speakers for this event; created a scientific two-day programme; reviewed and allocated abstracts; promoted the meeting with the Network community and relevant networks. |
| Collaborator Contribution | The Royal Society organised all meeting logistics at the Royal Society buildings in London, UK; promoted the event on the events page of their website and through various media channels; provided all on site logistics. |
| Impact | These are the key outcomes and recommendations from the 2 day meeting: Key outcomes: 1) AMR is a One Health problem with devastating health & economic consequences, particularly in LMICs 2) The importance of vaccines in addressing AMR is under-appreciated 3) Vaccines are an effective tool against AMR, both in humans and animals, but more evidence is needed 4) Limited vaccines are available against the bacterial pathogens which are responsible for 1.27 million AMR deaths/year 5) There is limited funding to develop new vaccines, despite an estimated economic cost of US$3-7 trillion/year by 2050 from AMR 6) The vaccine community must effectively communicate the role that vaccines play in reducing AMR Recommendations: 1) There is a critical need for a coordinated, multi-disciplinary One Health global approach to addressing the AMR crisis 2) Human and veterinary vaccine fields have a pivotal role to play and must work together in order to achieve this 3) The evidence that vaccines reduce AMR needs to be continually strengthened by scientific studies 4) Advocacy is required for funding to drive vaccine development and implementation, particularly in LMICs 5) Clear messaging is essential to articulate the importance of vaccines in AMR to stakeholders and policymakers globally |
| Start Year | 2023 |
| Title | BactiVac Network Members' Directory |
| Description | Contains members' profiles in order to identify potential collaborators. Network members can access full details of other members (via login) and can search the Directory by: - Name - Institution - Country - Research expertise |
| Type Of Technology | Webtool/Application |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | Members' Directory helps to encourage cross-collaboration between academic and industrial partners in developed and developing nations and to provide access to potential collaborators from multiple disciplines. |
| URL | https://bactivac.bham.ac.uk/ |
| Description | 18th Vaccine Congress |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The congress brings together leading experts from all over the world to share the latest cutting-edge discoveries in the field. We presented a poster on BactiVac. |
| Year(s) Of Engagement Activity | 2024 |
| Description | 5th EBCNet Meeting |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The EBCNet gathers around 300 principal investigators working in the field of B cell immunology from 22 European and affiliated countries. Lots of interest in vaccinology. |
| Year(s) Of Engagement Activity | 2024 |
| Description | AMR Royal Society meeting |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Broader contact with AMR stakeholders working in discipline other than vaccines. |
| Year(s) Of Engagement Activity | 2024 |
| Description | American Microbiology Society |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | One of the largest microbial science meetings in the world, gathering bringing together scientists, researchers, and healthcare professionals. Shigella researchers and manufacturing (Francesca Micoli presented too) |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://asm.org/Events/ASM-Microbe/Home |
| Description | BactiVac 5th Annual Network Meeting 2024 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | BactiVac held its 4th Annual Network Meeting 04 - 07 November 2024 in Ho Chi Minh City, Vietnam in collaboration with the The Oxford University Clinical Research Unit (OUCRU). We welcomed an attendance of 176 Network members from 32 different countries. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.birmingham.ac.uk/research/immunology-immunotherapy/research/bactivac/meetings-events/5th... |
| Description | BactiVac Network Advisory Board (NAB) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The BactiVac Network Advisory Board (NAB) is composed of senior members of the bacterial vaccinology community and is responsible for providing non-binding but informed guidance to the BactiVac Network Management Oversight Board (NMOB) which is chaired by the Director of the Network. The Advisory Board aim to meet a minimum of once per year. |
| Year(s) Of Engagement Activity | 2018,2019,2020,2021,2022,2023,2024,2025 |
| Description | BactiVac Network LinkedIn Account |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Metrics for the period 01/03/24 to 29/01/24: - Content: received 3,058 reactions, 76 comments and 31 reposts of our content - Visitors: 3,000 page views, 1,283 unique visitors and 3 custom button clicks - Followers: 1,829 page followers, 1,076 of which have been gained in the last 334 days Metrics for the period 01/03/23 to 28/02/24: - Content: received 1,164 reactions, 19 comments and 71 reposts of our content - Visitors: 3,088 page views, 1,059 unique visitors and 40 custom button clicks - Followers: 760 page followers, 535 of which have been gained in the last 365 days Metrics for the period 01/03/24 to 24/02/25: - Content: received 3,158 reactions, 87 comments and 32 reposts of our content - Visitors: 3,214 page views, 1,377 unique visitors and 3 custom button clicks - Followers: 1,878 page followers, 1,120 of which have been gained in the last 361 days |
| Year(s) Of Engagement Activity | 2022,2023,2024,2025 |
| URL | https://www.linkedin.com/company/bactivac/ |
| Description | BactiVac Network Management Oversight Board (NMOB) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The BactiVac Network Oversight Management Board (NMOB) is responsible for devising and reviewing BactiVac Network strategy, making decisions related to its implementation, based on recommendations from the Network Operations Management Group (NOMG). The Management Board aim to meet quarterly each year. |
| Year(s) Of Engagement Activity | 2018,2019,2020,2022,2023,2024,2025 |
| Description | BactiVac Network Members' Directory |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Between 1 July 2024 and 234 February 2025 Network Members' Directory had 7.914 page views and Avg. Time on Page was 1 min 21 sec. Data for the period between 12 March to 1 July 2024 is unavailable and so is not included in the figures given. |
| Year(s) Of Engagement Activity | 2024,2025 |
| URL | https://bactivac.bham.ac.uk/ |
| Description | BactiVac Network Membership |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | In 2025, BactiVac Network has 2118 members from across 92 countries. 43% are female members, 52% of our members are based in LMICs and the proportion of our industrial membership is 14%. |
| Year(s) Of Engagement Activity | 2024,2025 |
| URL | https://bactivac.bham.ac.uk/ |
| Description | BactiVac Network Newsletter |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | June 2024 Issue #22 - newsletter was sent to 1,801 members and open rate was 30.00% December 2024 Issue #23 - newsletter was sent to 1,994 members and open rate was 18.07% |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.birmingham.ac.uk/research/immunology-immunotherapy/research/bactivac/newsletters |
| Description | BactiVac Network Operational Management Group (NOMG) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | The BactiVac Network Operations Management Group (NOMG) is responsible for the day to day management and delivery of the BactiVac Network's strategy, making decisions related to its operational delivery. The NOMG meets once a month to discuss Network activities. |
| Year(s) Of Engagement Activity | 2011,2018,2019,2020,2021,2022,2023,2024,2025 |
| Description | BactiVac Network Twitter Account |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | As per 06 March 2019 we had 991 followers on Twitter. Number of followers have tripled since the launch of the Network in August 2017. As per 25 February 2021 we have 1,501 followers on Twitter. Number of followers have been increasing regularly since the launch of the Network in August 2017. As per 07 March 2022 we have 1,666 followers on Twitter. Number of followers have been increasing regularly since the launch of the Network in August 2017. As per 01 March 2024 BactiVac have 2,116 followers and posted a total of 4,827 times on Twitter. Number of impression for the period 01/03/23 to 28/02/24 was 129,500 As per 30 January 2025 BactiVac have 2,162 followers and posted a total of 227 times on Twitter. Number of impression for the period 01/03/24 to 30/01/24 was 93,484 |
| Year(s) Of Engagement Activity | 2017,2018,2019,2020,2021,2022,2023,2024,2025 |
| URL | https://twitter.com/BactiVac |
| Description | BactiVac Network website |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Between 12 March 2024 and 23 February 2025 Network website had 32,309 page views and Avg. Time on Page was 2 min 16 sec. |
| Year(s) Of Engagement Activity | 2024,2025 |
| URL | https://www.birmingham.ac.uk/research/immunology-immunotherapy/research/bactivac |
| Description | BactiVac Online: Journal Article Writing Course 2024 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | BactiVac Online Journal Article Writing Course for BactiVac members was delivered online on 26 & 28 November 2024 AND 3 & 5 December 2024. This online training course was delivered by an experienced and enthusiastic facilitators Dr Chris Pull and Dr Laura Knogler from Scriptoria (an award-winning company in the UK, specialising in knowledge and data management, communications and engagement, monitoring and learning, and training delivery). 24 Network members representing 15 different countries had the unique opportunity to learn and engage with their peers. Places for our online course were available for Network members only and were allocated via a competitive process. Scriptoria online courses were highly interactive and engaged participants through presentations, group discussions, partnered exercises and polls. All participants received a comprehensive set of course notes in addition to tools and software tips. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.birmingham.ac.uk/research/immunology-immunotherapy/research/bactivac/bactivac-online-tra... |
| Description | Biovac Visit |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Jamie was given a tour of Biovac facilities and gave a presentation on BactiVac. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Carbex satellite stakeholder meeting |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presentation on BactiVac. Very interested in our work, particularly LMIC engagement. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Clinical Immunoassays workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop in Oxford |
| Year(s) Of Engagement Activity | 2024 |
| Description | DCVMN Meeting |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The DCVMN's Annual General Meetings bring together vaccine manufacturing leaders, experts from multilateral health organisations, and high-profiled researchers to dialogue equitable development of vaccines for protecting people against emerging diseases. BactiVac came up a lot; Cal had a chance to catch-up with Ankur, Birgitte, Rajinder Suri, Syed Ahmed, CEO of Hilleman - Raman Rao. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://dcvmn.org/annual-general-meetings/ |
| Description | GSK Vaccine Virtual Days 2024 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Free medical education event to learn of the current trends, data and innovations surrounding the global adult immunisation community. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://vshow.on24.com/vshow/VVD/registration/23261?partnerref=NX-GBL-GVU-EML-230015 |
| Description | Global Health Research Showcase |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Event to showcase UoB's global health research, and to enable researchers, policy makers and other stakeholders to come together and network, with the focus on linking evidence to policy and practice. Adam participated in a panel discussion and spoke about BactiVac and it's success as a global network. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.ipcrg.org/news-and-events/university-of-birmingham-global-health-research-showcase |
| Description | Group B Strep in Pregnancy and babies |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Virtual conference designed for health professionals interested in group B Strep and working in maternity/neonatal care |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://gbss.org.uk/professional-resources/gbssconference2024/ |
| Description | IVVN Annual Network Meeting |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Aimed at academic researchers and industry representatives in the veterinary field. Speakers, abstract session, networking session. Jamie attended as a delegate. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.intvetvaccnet.co.uk/events/annual-conferences/international-veterinary-vaccinology-netwo... |
| Description | Immunity in pregnancy and in early life - lifelong impact on health |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Annual celebration of World Immunology Day. Our panel will explain our growing understanding of immunity in pregnancy and in early life, and highlight exciting recent breakthroughs made in this area. They will also discuss why certain vaccines are recommended during pregnancy. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.crick.ac.uk/whats-on/world-immunology-day-immunity-in-pregnancy-and-in-early-life-lifelo... |
| Description | Inaugural Australia's Vaccine Value Chain Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Australia's Vaccine Value Chain Conference 2024 is an exclusive invitation-only event, bridging the gaps in Australia's vaccine ecosystem to maximise health impact and unlock the nation's economic potential in global disease prevention, featuring insights from renowned international and local experts. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.mtpconnect.org.au/Event?Action=View&Event_id=1123 |
| Description | Infection Transmission Sandpit Event |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | This dynamic sandpit event will bring UK innovators together to build networks & shape future approaches to tackle the spread of infection |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.eventbrite.co.uk/e/infection-transmission-sandpit-event-london-tickets-844668836227 |
| Description | Institute of Immunology and Immunotherapy (III) Away Day |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Postgraduate students |
| Results and Impact | Adam gave a talk on Salmonella. Jamie and Georgia presented BactiVac poster, but not many people working on bacteria. |
| Year(s) Of Engagement Activity | 2024 |
| Description | International Masterclass AMR 2024 |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The International Masterclass AMR was designed for professionals who want to understand Antimicrobial Resistance (AMR) in a short time. Adam presented on 'Infection Prevention and Control and the key role of vaccination'. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.amr-insights.eu/international-masterclass-amr/ |
| Description | Joint Meeting of SAVAC and WHO Streptococcus pyogenes vaccines: an expert review of evidence needs to guide policy |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Good interaction with policy makers and regulators. Cal attended on behalf of Gates |
| Year(s) Of Engagement Activity | 2024 |
| Description | Lymphatic Tissues and Germinal Centres in Immune Reactions |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The meeting was aimed world experts and young researchers, facilitating debates of the key issues in our field and the future directions required. It was their largest meeting to date, not much work presented on bacterial vaccines but there was a lot of interest in it. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://meetings.embo.org/event/24-lymphatic-tissues |
| Description | Microbiology Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Opportunity to communicate UK and international activity, promoting bacterial vaccines and how it fits in with AMR. Introducing BactiVac's work in terms on AMR. Large representation from BactiVac board. |
| Year(s) Of Engagement Activity | 2025 |
| Description | OIG Symposium |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | A one-day showcase event of immunology research happening across Oxford with opportunities for cross-disciplinary collaboration and networking. Cal gave a presentation which mentioned BactiVac and Jamie had a branded stand with leaflets and BactiVac merchandise. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.immunology.org/events/oxford-immunology-symposium-24 |
| Description | Oxford Medical Lecture Club |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | 45 min lecture on vaccines & AMR including BactiVac slide. |
| Year(s) Of Engagement Activity | 2025 |
| URL | https://www.medsci.ox.ac.uk/about-us/alumni/events-and-reunions/oxford-medical-lecture-club |
| Description | Oxford Salmonella Assays & Standards |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Catalyst project that was awarded to Cal |
| Year(s) Of Engagement Activity | 2024 |
| Description | Press release to announce UKVN funding for £700k |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | press release published on the BactiVac website under the news section to announce additional funding awarded by UKVN |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.birmingham.ac.uk/news/2024/bactivac-network-awarded-700k-by-the-uk-vaccine-network-proje... |
| Description | Royal Society Meeting |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Science+ meeting organised by Professor Calman MacLennan and Dame Sally Davies FMedSci FRS. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://royalsociety.org/science-events-and-lectures/2024/04/vaccines-amr/ |
| Description | UCL School of Pharmacy/Royal Pharmaceutical Society annual lecture |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Attended by Richard Moxon and Peter Borriello. Put slide up on BactiVac in context of AMR/vaccines so good visibility. Useful link to pharmacists and parliament. Dr Zubir Ahmed MP , permanent private secretary to the secretary of state for Health and Social Care |
| Year(s) Of Engagement Activity | 2024 |
| Description | UK AMR Inward mission |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | The overall aim of the inward AMR Innovation Mission UK 2024 is to help the global curbing of Antimicrobial resistance ('AMR') by boosting collaboration and joint innovation with UK businesses. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.amr-insights.eu/inward-amr-im-uk-2024/ |
| Description | UKCVN conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Conference for healthcare professionals and academics interested in adult vaccine research and policy. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://cvnuk.co.uk/ |
| Description | UKHSA National Immunisation Network (NIN) Conference 2024 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Good link for BactiVac and UKHSA at speakers' dinner |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.somersetgpeducationtrust.co.uk/nationalimmunisationnetworkannualconferenceapril24252024r... |
| Description | Vaccines and how antibodies function against bacteria' |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Adam gave a presentation, including a slide on BactiVac to an audience of 40-50 non-clinical academics |
| Year(s) Of Engagement Activity | 2025 |
| Description | World Anti-microbial Awareness Week (WAAW) campaign |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | BactiVac had a social media campaign for World Antimicrobial Awareness Week consisting of several posts across the week. As part of the campaign we also produced a video interview with the World Health Origanization's Annalies Wilder-Smith, discussing vaccines as a tool against AMR. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://x.com/BactiVac/status/1859599144488259816 |
| Description | World Vaccine Congress Europe |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Academic researchers, Industry and Funding representatives (Both Human and Veterinary). BactiVac had a booth which had a lot of attention, Jamie presented a poster, Christine Rollier presented a poster, was a panellist at the platforms technology workshop, Christine presented a talk titled , 'Strategies for Developing Bacterial Vaccines in a One Health Framework.' |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.terrapinn.com/conference/world-vaccine-congress-europe/index.stm |